市場調查報告書

全球寵物疫苗市場:各產品類型,類別,流通管道,地區 - 市場規模,佔有率,預測,及機會分析

Companion Animal Vaccines Market, By Product Type, By Species Type, By Distribution Channel, and By Regions - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 924603
出版日期 內容資訊 英文 178 Pages
商品交期: 2-3個工作天內
價格
全球寵物疫苗市場:各產品類型,類別,流通管道,地區 - 市場規模,佔有率,預測,及機會分析 Companion Animal Vaccines Market, By Product Type, By Species Type, By Distribution Channel, and By Regions - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年01月30日內容資訊: 英文 178 Pages
簡介

本報告提供全球寵物疫苗市場的相關調查,提供市場機會和課題,成長及阻礙因素,各產品類型·類別·流通管道·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的·前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
  • 市場定義和範圍
  • 摘要整理
  • 各產品類型
  • 類別
  • 各流通管道
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

    • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析
    • 主要的開發
    • 產品的銷售
    • 法規方案

第4章 市場分析:各產品類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 減毒活病毒疫苗
  • 結合物疫苗
  • 不活化疫苗
  • 次單元疫苗
  • 類毒素疫苗
  • DNA疫苗
  • 重組疫苗

第5章 市場分析:類別

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 鳥類

第6章 市場分析:各流通管道

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 獸醫診所
  • 獸醫醫院
  • 獸醫研究所
  • 零售藥局·其他

第7章 市場分析:各地區

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • Bayer Healthcare
  • Vetoquinol S.A
  • Boehringer Ingelheim
  • Ceva Sante Animal S.A.
  • Eli Lilly and Company (Elcano)
  • Heska Co.
  • Merck Animal Health
  • Merial (Boehringer Ingelheim)
  • Virbac
  • Zoetis

第9章 章節

    • 參照資料
    • 調查方法
    • 關於本公司
目錄

Companion animal vaccines are used to protect and treat companion animals such as cats, and dogs from diseases such as infectious canine hepatitis, parvovirus, rabies, and etc. Increasing expenditure on animal healthcare, increasing pet ownership, increasing incidence and prevalence of zoonotic disease, are major driver attributing to the growth of global companion animal vaccines market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the global Companion Animal Vaccines and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Companion Animal Vaccines based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva Sante Animal S.A., Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Merial (Boehringer Ingelheim),Virbac, and Zoetis.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Companion Animal Vaccines report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Companion Animal Vaccines Market, By Product Type:
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Companion Animal Vaccines Market, By Species Type:
    • Canine
    • Avian
    • Feline
  • Companion Animal Vaccines Market, By Distribution Channel:
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Retail Pharmacies & Others
  • Companion Animal Vaccines Market, By Region:
    • North America
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Attenuated Live Vaccines
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • Toxoid Vaccines
      • DNA Vaccines
      • Recombinant Vaccines
      • By Species
      • Canine
      • Avian
      • Feline
      • By Distribution Channel
      • Veterinary Clinics
      • Veterinary Hospitals
      • Veterinary Research Institutes
      • Retail Pharmacies & Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Bayer Healthcare *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Vetoquinol S.A
    • Boehringer Ingelheim
    • Ceva Sante Animal S.A.
    • Eli Lilly and Company (Elcano)
    • Heska Co.
    • Merck Animal Health
    • Merial (Boehringer Ingelheim)
    • Virbac
    • Zoetis

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Species
    • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Product Launch
    • Regulatory Scenario

4. Global Companion Animal Vaccines Market, By Product Type, 2019 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Attenuated Live Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Conjugate Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Inactivated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Subunit Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Toxoid Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • DNA Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Recombinant Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

5. Global Companion Animal Vaccines Market, By Species, 2019 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Canine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Avian
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Feline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

6. Global Companion Animal Vaccines Market, By Distribution Channel, 2019 - 2027, (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
    • Veterinary Clinics
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Veterinary Hospitals
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Veterinary Research Institutes
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Retail Pharmacies & Others
    • Introduction
    • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Electronic Medical Records Market, By Region, 2019 - 2027, (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
    • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Species, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

    • Company Profiles
    • Bayer Healthcare
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Vetoquinol S.A
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Ceva Sante Animal S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eli Lilly and Company (Elcano)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Heska Co.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck Animal Health
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merial (Boehringer Ingelheim)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Virbac
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Zoetis
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact